闭合切口负压治疗减少DIEP皮瓣乳房再造供区并发症的成本效益分析
该回顾性病例对照研究在单中心比较了DIEP皮瓣供区使用闭合切口负压治疗(ciNPT,n=24)与常规术后敷料(n=20)的效果。ciNPT组供区并发症(p=0.018)、手术部位感染(p=0.014)和血清肿(p=0.016)均显著减少。成本效益分析显示ciNPT组每例患者并发症相关成本平均降低420.77英镑(p=0.031),计入术后住院时间后降低446.47英镑(p=0.049)。
要点
- ciNPT组供区并发症、手术部位感染和血清肿发生率均显著低于常规敷料组。
- ciNPT组每例患者并发症相关成本平均降低420.77英镑(p=0.031)。
- 计入术后住院时间后,ciNPT组每例患者成本平均降低446.47英镑(p=0.049)。
核心结论
- ciNPT似乎是有效的切口管理替代系统,可能改善DIEP皮瓣供区的并发症发生率和术后发病率。
- 分析显示成本效益改善,超过了ciNPT相关成本的增加。
- 作者推荐开展多中心前瞻性试验并进行正式的成本效用分析以强化这些发现。
研究设计与样本
- 回顾性病例对照研究,单中心,2017年3月至2021年9月。
- 纳入接受DIEP皮瓣微血管自体乳房再造的患者。
- ciNPT组n=24,常规术后伤口敷料组n=20。
- 比较两组患者人口学特征、伤口引流量和术后结局,并进行成本效益分析。
主要发现
- 两组年龄、体质指数(BMI)、合并症负担或吸烟状态无统计学显著差异。
- 两组住院时间和伤口引流量相似,两组均无再入院或再手术。
- ciNPT组供区并发症显著减少(p=0.018)。
- ciNPT组手术部位感染显著减少(p=0.014)。
- ciNPT组血清肿形成显著减少(p=0.016)。
关键数值与推荐
- ciNPT组每例患者并发症相关成本平均降低420.77英镑(p=0.031)。
- 计入术后住院时间后,ciNPT组每例患者成本平均降低446.47英镑(p=0.049)。
临床怎么用
- 作者推荐开展多中心前瞻性试验并进行正式的成本效用分析以强化这些发现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Deep inferior epigastric perforator (DIEP) flaps are considered the gold standard for autologous breast reconstruction but create large abdominal incisions that risk donor-site morbidity during harvest. Closed incision negative pressure therapy (ciNPT) is emerging as an effective alternative to standard postoperative dressings, but there is a paucity of data in DIEP flap donor sites. METHODS: We conducted a retrospective case-control study investigating the use of ciNPT in DIEP flap donor sites at a single institution between March 2017 and September 2021. Patients who underwent microsurgical autologous breast reconstruction with DIEP flaps were included. Patients were divided into those with donor incision sites managed with ciNPT (n = 24) and those with conventional postoperative wound dressings (n = 20). We compared patient demographics, wound drainage volumes and postoperative outcomes between the two groups. A cost-benefit analysis was employed to compare the overall costs associated with each complication and differences in length of stay between the two groups. RESULTS: There was no statistically significant difference in age, body mass index (BMI), comorbidity burden or smoking status between the two groups. Both groups had similar lengths of stay and wound drainage volumes with no readmissions or reoperations in either group. There was a statistically significant reduction in donor-site complications (p = 0.018), surgical site infections (p = 0.014) and seroma formation (p = 0.016) in those with ciNPT. Upon cost-benefit analysis, the ciNPT group had a mean reduction in cost-per-patient associated with postoperative complications of £420.77 (p = 0.031) and £446.47 (p = 0.049) when also accounting for postoperative length of stay CONCLUSION: ciNPT appears to be an effective alternative incision management system with the potential to improve complication rates and postoperative morbidity in DIEP flap donor sites. Our analysis demonstrates improved cost-benefit outweighing the increase in costs associated with ciNPT. We recommend a multicentre prospective trial with formal cost-utility analysis to strengthen these findings.
引用
- Munro SP, Dearden A, Joseph M, et al. Reducing donor-site complications in DIEP flap breast reconstruction with closed incisional negative pressure therapy: A cost-benefit analysis. J Plast Reconstr Aesthet Surg. 2022. PMID: 36739647. doi:10.1016/j.bjps.2022.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。